StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
79
This month
1
This week
1
This year
7
Yesterday
1
Publishing Date
2023 - 11 - 02
3
2023 - 10 - 25
2
2023 - 09 - 07
1
2023 - 08 - 03
2
2023 - 07 - 20
1
2023 - 07 - 19
1
2023 - 07 - 17
1
2023 - 05 - 04
1
2023 - 04 - 20
1
2023 - 02 - 23
2
2023 - 02 - 02
1
2022 - 11 - 03
1
2022 - 10 - 27
1
2022 - 10 - 13
1
2022 - 09 - 08
1
2022 - 08 - 11
1
2022 - 08 - 09
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 18
1
2022 - 06 - 02
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 02 - 24
1
2022 - 02 - 10
1
2022 - 01 - 24
1
2022 - 01 - 21
2
2022 - 01 - 14
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 12 - 12
1
2021 - 12 - 09
1
2021 - 11 - 13
1
2021 - 11 - 09
1
2021 - 11 - 05
2
2021 - 10 - 28
1
2021 - 10 - 27
1
2021 - 10 - 19
1
2021 - 10 - 14
1
2021 - 10 - 04
1
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 21
2
2021 - 05 - 15
1
2021 - 05 - 03
2
2021 - 04 - 29
1
2021 - 04 - 19
2
2021 - 04 - 15
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 01 - 28
1
2021 - 01 - 07
1
Sector
Health technology
79
Tags
Alcohol use disorder
3
Alzheimer’s
5
Application
12
Approval
13
Biotech
7
Biotech-bay
7
Cancer
10
Chronic hepatitis b
4
Clinical-trials-phase-i
6
Clinical-trials-phase-ii
4
Clinical-trials-phase-iii
14
Collaboration
4
Conference
19
Day
5
Disease
13
Drug
11
Earnings
21
Europe
5
Events
26
Fda
9
Financial
21
Financial results
13
Food
5
Genetown
37
Global
4
Growth
5
Hepatitis
19
Hypertension
5
Iot
7
Kidney
4
Leo
4
Liver
16
Market
10
Media
4
Meeting
6
N/a
80
New drug
4
Ongoing
5
People
9
Pharma
4
Pharmaceuticals
6
Phase 1
7
Phase 2
11
Phase 3
23
Positive
19
Potential
4
Presentation
12
Program
6
Report
10
Research
19
Results
79
Study
12
Technology
12
Therapeutics
9
Topline
7
Treatment
38
Trial
12
Update
6
Vir-2218
4
Year
7
Entities
2seventy bio, inc.
1
Abbvie inc.
1
Alnylam pharmaceuticals, inc.
79
Biogen inc.
1
Checkmate pharmaceuticals, inc.
1
Eli lilly and company
6
Gilead sciences, inc.
1
Intellia therapeutics, inc.
2
Ionis pharmaceuticals, inc.
2
Johnson & johnson
2
Moderna, inc.
1
Novo nordisk a/s
6
Pfizer, inc.
1
Pulse biosciences, inc
1
Reata pharmaceuticals, inc.
1
Regeneron pharmaceuticals, inc.
5
Sanofi
26
Summit therapeutics inc.
1
Vir biotechnology, inc.
6
Xencor, inc.
4
Symbols
ABBV
80
AEM
39
ALNY
79
AMGN
53
APO
41
ARVL
178
AUY
39
BAM
52
BGNE
50
BIDU
39
BMY
64
BNPQF
73
BNPQY
73
BNTX
51
CHRS
45
CYTK
41
DAO
46
DRTT
38
FBIO
60
FNCTF
330
FRBA
87
GILD
51
GOLD
48
INCY
72
IONS
42
JD
40
JKS
38
JNJ
218
LGND
44
LLY
203
LTUM
59
LXRX
40
MDWD
48
MPC
53
MPLX
53
MS
205
NEE
43
NEP
42
NTES
57
NVS
52
NVSEF
38
PAYD
167
PFE
62
PGR
38
PPRUF
77
PPRUY
77
PRVB
41
REGN
84
SGEN
38
SNY
366
SNYNF
291
SRE
40
TAK
58
TEVJF
47
TK
48
TNK
47
TTOO
42
UAN
42
XNCR
39
XYF
94
Exchanges
Nasdaq
79
Nyse
10
Crawled Date
2023 - 11 - 02
2
2023 - 10 - 25
2
2023 - 10 - 19
1
2023 - 09 - 07
1
2023 - 08 - 03
2
2023 - 07 - 20
1
2023 - 07 - 19
1
2023 - 07 - 17
1
2023 - 05 - 04
1
2023 - 04 - 20
1
2023 - 02 - 23
2
2023 - 02 - 02
1
2022 - 11 - 03
1
2022 - 10 - 27
1
2022 - 10 - 13
1
2022 - 09 - 08
1
2022 - 08 - 11
1
2022 - 08 - 09
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 18
1
2022 - 06 - 02
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 02 - 25
1
2022 - 02 - 10
1
2022 - 01 - 24
1
2022 - 01 - 21
2
2022 - 01 - 14
1
2021 - 12 - 14
2
2021 - 12 - 12
1
2021 - 12 - 09
1
2021 - 11 - 13
1
2021 - 11 - 09
1
2021 - 11 - 05
2
2021 - 10 - 28
1
2021 - 10 - 27
1
2021 - 10 - 19
1
2021 - 10 - 14
1
2021 - 10 - 04
1
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 21
2
2021 - 05 - 15
1
2021 - 05 - 03
2
2021 - 04 - 29
1
2021 - 04 - 19
2
2021 - 04 - 15
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 01 - 28
1
2021 - 01 - 07
1
Crawled Time
00:00
3
01:00
1
03:00
1
04:20
1
08:00
1
09:00
1
10:00
1
11:00
1
12:00
7
12:15
2
12:20
2
12:30
1
13:00
15
13:15
2
13:20
3
13:30
1
14:00
5
14:30
3
15:00
4
15:30
1
16:00
2
16:20
2
18:00
2
19:00
4
20:00
1
20:20
2
21:00
2
22:00
6
23:00
2
Source
www.alnylam.com
16
www.biospace.com
57
www.globenewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Results
symbols :
ALNY
save search
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-1.06%
|
O:
-1.17%
H:
1.01%
C:
0.11%
first
conference
financial
results
Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session
Published:
2024-03-20
(Crawled : 13:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-2.03%
|
O:
-0.11%
H:
0.43%
C:
-0.01%
cardiology
results
study
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published:
2024-03-05
(Crawled : 16:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.17%
|
O:
1.17%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-3.25%
|
O:
-0.73%
H:
1.52%
C:
0.5%
positive
blood
care
topline
results
study
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-22
(Crawled : 00:00)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-20.84%
|
O:
-0.87%
H:
2.89%
C:
2.14%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-18.4%
|
O:
-0.69%
H:
2.99%
C:
2.59%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-6.19%
|
O:
-0.17%
H:
6.18%
C:
5.4%
year
update
financial
results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity
Published:
2024-02-15
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.49%
|
O:
1.16%
H:
1.48%
C:
0.89%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.33%
|
O:
1.86%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-11.57%
|
O:
-8.62%
H:
2.18%
C:
-1.71%
year
pharmaceuticals
financial
results
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published:
2024-02-02
(Crawled : 12:00)
- globenewswire.com
TSVT
|
$4.52
-2.59%
-2.65%
610K
|
|
-2.5%
|
O:
-1.16%
H:
9.94%
C:
2.34%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.09%
|
O:
-0.93%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-5.91%
|
O:
1.4%
H:
0.28%
C:
-2.68%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-17.01%
|
O:
-1.23%
H:
1.0%
C:
0.17%
year
financial
results
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-01-29
(Crawled : 14:30)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-19.18%
|
O:
-0.27%
H:
1.32%
C:
1.02%
conference
year
financial
results
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
Published:
2023-11-07
(Crawled : 15:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
16.48%
|
O:
-0.28%
H:
0.0%
C:
0.0%
SMMT
A
|
$3.51
0.0%
1.7M
|
Health Technology
|
63.76%
|
O:
-0.46%
H:
6.68%
C:
-11.75%
PLSE
|
$7.2
-2.17%
-2.22%
180K
|
Health Technology
|
43.93%
|
O:
0.39%
H:
6.43%
C:
1.92%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-21.51%
|
O:
-0.82%
H:
0.73%
C:
-0.4%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-13.16%
|
O:
1.06%
H:
2.42%
C:
0.76%
therapeutics
financial
results
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published:
2023-11-02
(Crawled : 00:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.7%
|
O:
-0.89%
H:
0.0%
C:
0.0%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
9.16%
|
O:
1.32%
H:
0.45%
C:
-1.19%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
5.91%
|
O:
1.03%
H:
4.07%
C:
4.07%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-7.54%
|
O:
3.4%
H:
0.57%
C:
-0.5%
update
financial
results
Alnylam Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Period Activity
Published:
2023-11-02
(Crawled : 13:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.28%
|
O:
3.0%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-7.54%
|
O:
3.4%
H:
0.57%
C:
-0.5%
pharmaceuticals
financial
results
Regeneron Reports Third Quarter 2023 Financial and Operating Results
Published:
2023-11-02
(Crawled : 11:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.28%
|
O:
3.0%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
13.89%
|
O:
0.08%
H:
4.96%
C:
3.4%
NTLA
|
$21.57
1.17%
1.16%
1.4M
|
Health Technology
|
-16.39%
|
O:
2.35%
H:
1.63%
C:
1.46%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-7.54%
|
O:
3.4%
H:
0.57%
C:
-0.5%
financial
results
Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine
Published:
2023-10-25
(Crawled : 23:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.43%
|
O:
0.4%
H:
1.29%
C:
1.29%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.13%
|
O:
1.43%
H:
0.64%
C:
-0.09%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-11.47%
|
O:
-1.28%
H:
0.58%
C:
-1.46%
publication
results
study
Alnylam Reports Additional Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published:
2023-10-25
(Crawled : 19:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.43%
|
O:
0.4%
H:
1.29%
C:
1.29%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.13%
|
O:
1.43%
H:
0.64%
C:
-0.09%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-11.47%
|
O:
-1.28%
H:
0.58%
C:
-1.46%
disease
alzheimer’s
positive
results
Alnylam to Webcast Conference Call Discussing Third Quarter 2023 Financial Results
Published:
2023-10-19
(Crawled : 13:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-12.07%
|
O:
0.13%
H:
0.23%
C:
-2.9%
conference
financial
results
Alnylam Reports Positive Topline Results from KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development to Treat Hypertension in Patients at High Cardiovascular Risk
Published:
2023-09-07
(Crawled : 14:30)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.61%
|
O:
1.03%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-27.94%
|
O:
-0.15%
H:
1.32%
C:
-0.02%
positive
treat
risk
topline
hypertension
cardiovascular
results
study
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Published:
2023-08-03
(Crawled : 20:00)
- globenewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.72%
|
O:
0.19%
H:
0.0%
C:
0.0%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-18.33%
|
O:
7.75%
H:
4.65%
C:
-3.9%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-40.94%
|
O:
-0.36%
H:
2.51%
C:
-2.16%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-23.64%
|
O:
-0.42%
H:
0.0%
C:
-1.97%
update
financial
results
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
Published:
2023-08-03
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.05%
|
O:
-1.6%
H:
0.11%
C:
0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.72%
|
O:
-3.79%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-21.37%
|
O:
-1.35%
H:
5.58%
C:
4.38%
pharmaceuticals
financial
results
Alnylam to Webcast Conference Call Discussing Second Quarter 2023 Financial Results
Published:
2023-07-20
(Crawled : 13:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-29.3%
|
O:
-0.48%
H:
1.1%
C:
-1.41%
conference
financial
results
Alnylam Announces Publication of Phase 1 Study Results for Zilebesiran in the New England Journal of Medicine
Published:
2023-07-19
(Crawled : 22:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.86%
|
O:
0.88%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-30.35%
|
O:
0.74%
H:
0.28%
C:
-2.21%
publication
results
study
Alnylam Reports Updated Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published:
2023-07-17
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.66%
|
O:
0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
25.42%
|
O:
0.05%
H:
1.33%
C:
0.38%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-26.35%
|
O:
5.53%
H:
5.23%
C:
-2.49%
disease
alzheimer’s
positive
results
← Previous
1
2
3
4
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.